Hadasit Bio-Holdings

Hadasit Bio-Holdings is a publicly traded investment vehicle based in Jerusalem, Israel, commercializing intellectual property and R&D from Hadassah University Hospital by investing in biotech portfolio companies. It advances these companies through Phase I/II clinical trials after preclinical success, raising capital via public markets and private placements. It raised $8 million in its IPO and $19 million additionally through later financings; its parent, Hadasit Ltd., has spun off over 50 companies to date. Chairman Tamar Raz and CEO Tami Kfir, appointed in 2014, oversee portfolio companies such as KAHR Medical, which raised $2.6 million in 2012 and focuses on cancer and autoimmune diseases, attracting investors like Sanofi. Hadasit Bio-Holdings was established in 2006 as a subsidiary of Hadasit Ltd.